1193294

Blueprint Medicines Corporation — FEI 3011881091

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 18, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cambridge, MA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)